Experience and Expertise in Deriving Multi-target Lead Compounds
Core Technology(1) Development of SyMthomics Platform
Core Technology(2) Establishment of Advanced CMC Infrastructure
[IP Achievement] European Patent (EP) Grant for Neurodegenerative Disease Treatment Technology Derived from D...
Summary:Mthera Pharma’s proprietary technology for a pharmaceutical composition utilizing "Daphne genkwa flowe...
[R&D Achievement] Identification of New Proteasome API (Active Pharmaceutical Ingredient) in MT101 via...
[Press Release] NeuroBo Pharmaceuticals Announces Exclusive License Agreement with MThera Pharma for N...